Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05855382Completed

Prevalence of Persistent COVID-19 in Punta Arenas, Magallanes and Chilean Antarctic Region

Role: collaborator

NCT07497230Not ApplicableCompleted

Asymmetric High-Flow Nasal Cannula During Pulmonary Rehabilitation in COPD

Role: lead

NCT04504968Not ApplicableUnknown

Effectiveness of a Multimodal Intervention on Function in Older Frail People With Diabetes in Latinamerican

Role: collaborator

NCT03515642Not ApplicableWithdrawn

Exercise, Gut Microbiota in Sedentary Adults With Overweight

Role: collaborator

NCT02753231Not ApplicableCompleted

Exercise Training and Hepatic Metabolism in Overweight/Obese Adolescent

Role: collaborator

All 5 trials loaded